This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
The purpose of this study is to understand the occurrence of DKA in people with type 1 diabetes which will subsequently inform the benefit of continuous glucose and ketone monitoring in this population.
Study Type
OBSERVATIONAL
Enrollment
1,200
Participant will utilize the Abbott Continuous Dual Glucose Ketone Monitoring System in place of the Standard of Care
Optimal Clinical Trials (North)
Rosedale, Auckland, New Zealand
New Zealand Clinical Research
Christchurch, Christchurch Central City, New Zealand
Health New Zealand-Southern
Dunedin, Otago, New Zealand
Optimal Clinical Trials
Auckland, New Zealand
Primary Objective
Occurrence of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with type 1 diabetes while managing diabetes with the Abbott's Continuous Dual Glucose Ketone Monitoring System.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Aotearoa Diabetes Collective
Hamilton, New Zealand
Te Pae Hauora o Ruahine o Tararua /MidCentral Health New Zealand
Palmerston North, New Zealand
New Zealand Clinical Research
Wellington, New Zealand